Cui Jingrong Jean 4
4 · Turning Point Therapeutics, Inc. · Filed Jun 10, 2020
Insider Transaction Report
Form 4
Cui Jingrong Jean
DirectorChief Scientific Officer
Transactions
- Sale
Common Stock
2020-06-09$63.80/sh−412$26,286→ 549,471 total(indirect: By Spouse) - Sale
Common Stock
2020-06-09$64.82/sh−1,688$109,416→ 547,783 total(indirect: By Spouse) - Sale
Common Stock
2020-06-09$66.60/sh−2,585$172,161→ 540,683 total(indirect: By Spouse) - Sale
Common Stock
2020-06-09$65.80/sh−4,515$297,087→ 543,268 total(indirect: By Spouse) - Sale
Common Stock
2020-06-09$67.48/sh−300$20,244→ 540,383 total(indirect: By Spouse)
Holdings
- 1,001,298
Common Stock
- 300,000(indirect: By The Jean Cui 2020 GRAT)
Common Stock
Footnotes (6)
- [F1]Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li.
- [F2]The weighted average sale price for the transaction reported was $63.80, and the range of prices were between $63.25 and $64.20. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- [F3]The weighted average sale price for the transaction reported was $64.82, and the range of prices were between $64.26 and $65.17. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- [F4]The weighted average sale price for the transaction reported was $65.80, and the range of prices were between $65.26 and $66.24. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- [F5]The weighted average sale price for the transaction reported was $66.60, and the range of prices were between $66.27 and $67.18. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- [F6]The weighted average sale price for the transaction reported was $67.48, and the range of prices were between $67.34 and $67.915. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.